184 related articles for article (PubMed ID: 37840030)
1. Pharmacogenomics and adverse effects of anti-infective drugs in children.
Huang X; Hu B; Ye L; Li T; He L; Tan W; Yang G; Liu JP; Guo C
Clin Exp Pharmacol Physiol; 2024 Jan; 51(1):3-9. PubMed ID: 37840030
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships andz interindividual variability of drug responses: pharmacogenomics with antimicrobial drugs as a paradigm.
Thabet RH; Alshar BOS; Alabdallah DHS; Alhmoud NAZA; Alslameen STA; Thabet YRH
J Int Med Res; 2023 Nov; 51(11):3000605231214065. PubMed ID: 38019107
[TBL] [Abstract][Full Text] [Related]
3. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
4. Clinical association between pharmacogenomics and adverse drug reactions.
Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests.
Khan DA
J Allergy Clin Immunol; 2016 Oct; 138(4):943-955. PubMed ID: 27720019
[TBL] [Abstract][Full Text] [Related]
6. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
[TBL] [Abstract][Full Text] [Related]
7. The role of pharmacogenomics in adverse drug reactions.
Cacabelos R; Cacabelos N; Carril JC
Expert Rev Clin Pharmacol; 2019 May; 12(5):407-442. PubMed ID: 30916581
[TBL] [Abstract][Full Text] [Related]
8. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pharmacogenomic evidence for drugs related to
Reeves AA; Hopefl R; Deb S
Drug Metab Pers Ther; 2023 Mar; 38(1):65-78. PubMed ID: 36257916
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Pharmacogenomics of Adverse Drug Reactions.
Collins SL; Carr DF; Pirmohamed M
Drug Saf; 2016 Jan; 39(1):15-27. PubMed ID: 26650062
[TBL] [Abstract][Full Text] [Related]
12. Progression of precision statin prescribing for reduction of statin-associated muscle symptoms.
Petry NJ; Baye JF; Frear S; Jacobsen K; Massmann A; Schultz A; Heukelom JV; Christensen K
Pharmacogenomics; 2022 Jul; 23(10):585-596. PubMed ID: 35775396
[No Abstract] [Full Text] [Related]
13. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
Zhang Z; Wu Y; Tan NC; Jiang Y
Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy and pharmacogenomics--hopes and facts].
Müller-Zellenberg U; Müller M
Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
16. Pediatric perspective on pharmacogenomics.
Stevens A; De Leonibus C; Hanson D; Whatmore A; Murray P; Donn R; Meyer S; Chatelain P; Clayton P
Pharmacogenomics; 2013 Nov; 14(15):1889-905. PubMed ID: 24236488
[TBL] [Abstract][Full Text] [Related]
17. Identification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of Brazil.
Camargo AC; Matte U; Botton MR
Expert Opin Drug Saf; 2023; 22(7):621-627. PubMed ID: 36794346
[TBL] [Abstract][Full Text] [Related]
18. Considerations of pharmacogenetic testing in children.
Haga SB; Solomon BD
Pharmacogenomics; 2016 Jun; 17(9):975-7. PubMed ID: 27248426
[No Abstract] [Full Text] [Related]
19. Pharmacogenomics in children.
Rieder M
Methods Mol Biol; 2014; 1175():687-707. PubMed ID: 25150881
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
